NCT00449709View on ClinicalTrials.gov

A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2007

Conditions
Obstetric Labour, PrematurePremature Ejaculation
Interventions
DRUG

GSK221149

Trial Locations (1)

98418

GSK Investigational Site, Tacoma

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY